Canada's Pascal Biosciences partners with SoRSE to test cannabis-based cancer therapyPosted by On

(Reuters) – Canadian biotech Pascal Biosciences Inc will start an early stage study of a cannabis-based cancer therapy in partnership with SoRSE Technology Corp, the companies told Reuters on Monday.

Seattle, Washington-based SoRSE’s technology helps create water-soluble cannabidiol, a non-psychoactive chemical found in cannabis plants that is being widely used to make beverages, chocolates, lotions and other products.

Chief Executive Officer Howard Lee said SoRSE would pay Pascal for research expenses as it tests the experimental treatment PAS-393, which the companies hope can complement the so-called checkpoint inhibitors thought to help take the brakes off the immune system in fighting cancer.

“We’ve got the drug discovery and development expertise and SoRSE has formulation capabilities and that will help get the drug into the clinic,” said Pascal Chief Executive Officer Patrick Gray, adding the companies hope to begin Phase I trials over the…

Original Author Link click here to read complete story..



Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.